Engineering liver

Hepatology

Volumn 60, Issue 4, 2014, Pages 1426-1434

  Griffith, Linda G ^a   Wells, Alan ^b   Stolz, Donna B ^b  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL COMMUNICATION; CELL TRANSPLANTATION; CELL VIABILITY; CLINICAL TRIAL (TOPIC); DRUG METABOLISM; EXTRACELLULAR MATRIX; HEPATOCYTE TRANSPLANTATION; HUMAN; ILLUMINATION; IN VITRO STUDY; LIVER; LIVER CELL; LIVER DISEASE; LIVER ENGINEERING; LIVER INJURY; LIVER SUPPORT; MEDICAL TECHNOLOGY; MICROFLUIDICS; MICROTECHNOLOGY; NONHUMAN; ORGAN DONOR; ORGANOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVERSE ENGINEERING; REVIEW; STEM CELL; SYSTEMS BIOLOGY; TISSUE ENGINEERING; TISSUE REGENERATION; ANIMAL; BIOENGINEERING; COMPUTER SIMULATION; DISEASE MODEL; LIVER DISEASES; PHYSIOLOGY; TRENDS;

ANIMALS; BIOENGINEERING; COMPUTER SIMULATION; DISEASE MODELS, ANIMAL; HUMANS; LIVER; LIVER DISEASES; SYSTEMS BIOLOGY;

EID: 84927568897     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27150     Document Type: Review

References (62)

1. Griffith LG, Naughton G. Tissue engineering-current challenges and expanding opportunities. Science 2002;295:1009-1014.
2. Griffith LG, Swartz MA. Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol 2006;7:211-224.
3. Griffith LG, Wu B, Cima MJ, Powers MJ, Chaignaud B, Vacanti JP. In vitro organogenesis of liver tissue. Ann N Y Acad Sci U S A 1997;831:382-397.
4. Ananthanarayanan A, Narmada BC, Mo X, McMillian M, Yu H. Purpose-driven biomaterials research in liver-tissue engineering. Trends Biotech 2011;29:110-118.
5. Lee M, Wu BM. Recent advances in 3D printing of tissue engineering scaffolds. In: Methods in Molecular Biology™. Totowa, NJ: Humana Press; 2012:257-267.
6. Billiet T, Vandenhaute M, Schelfhout J, Van Vlierberghe S, Dubruel P. A review of trends and limitations in hydrogel-rapid prototyping for tissue engineering. Biomaterials 2012;33:6020-6041.
7. Derby B. Printing and prototyping of tissues and scaffolds. Science 2012;338:921-926.
8. Mironov V, Kasyanov V, Markwald RR. Organ printing: from bioprinter to organ biofabrication line. Curr Opin Biotech 2011;22:667-673.
9. Baranski JD, Chaturvedi RR, Stevens KR, Eyckmans J, Carvalho B, Solorzano RD, et al. Geometric control of vascular networks to enhance engineered tissue integration and function. Proc Natl Acad Sci U S A 2013;110:7586-7591.
10. Gerlach JC, Zeilinger K, Patzer Ii JF. Bioartificial liver systems: why, what, whither? Regen Med 2008;3:575-595.
11. Puppi J. Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London. Cell Transplant 2012;21:1-10.
12. Khan AA, Shaik MV, Parveen N, Rajendraprasad A, Aleem MA, Habeeb MA, et al. Human fetal liver-derived stem cell transplantation as supportive modality in the management of end-stage decompensated liver cirrhosis. Cell Transplant 2012;19:409-418.
13. Grompe M, Strom S. Mice with human livers. Gastroenterology 2013;145:1209-1214.
14. Friedman SL, Sheppard D, Duffield JS, Violette S. Therapy for fibrotic diseases: nearing the starting line. Sci Transl Med 2013;5:167sr1.
15. Schuppan D, Kim YO. Evolving therapies for liver fibrosis. J Clin Invest 2013;123:1887-1901.
16. Khetan S, Guvendiren M, Legant WR, Cohen DM, Chen CS, Burdick JA. Degradation-mediated cellular traction directs stem cell fate in covalently crosslinked three-dimensional hydrogels. Nat Mater 2013;12:458-465.
17. Olsen AL, Bloomer SA, Chan EP, Gaca MDA, Georges PC, Sackey B, et al. Hepatic stellate cells require a stiff environment for myofibroblastic differentiation. Am J Physiol Gastrointest Liver Physiol 2011;301:G110-G118.
18. Mehta G, Williams CM, Alvarez L, Lesniewski M, Kamm RD, Griffith LG. Synergistic effects of tethered growth factors and adhesion ligands on DNA synthesis and function of primary hepatocytes cultured on soft synthetic hydrogels. Biomaterials 2010;31:4657-4671.
19. Lozoya OA, Wauthier E, Turner RA, Barbier C, Prestwich GD, Guilak F, et al. Regulation of hepatic stem/progenitor phenotype by microenvironment stiffness in hydrogel models of the human liver stem cell niche. Biomaterials 2011;32:7389-7402.
20. Maheshwari G, Brown G, Lauffenburger DA, Wells A, Griffith LG. Cell adhesion and motility depend on nanoscale RGD clustering. J Cell Sci 2000;113:1677-1686.
21. Barker TH. The role of ECM proteins and protein fragments in guiding cell behavior in regenerative medicine. Biomaterials 2011;32:4211-4214.
22. Turturro MV, Christenson MC, Larson JC, Young DA, Brey EM, Papavasiliou G. MMP-sensitive PEG diacrylate hydrogels with spatial variations in matrix properties stimulate directional vascular sprout formation. PLoS One 2013;8:e58897.
23. Martino MM, Briquez PS, Ranga A, Lutolf MP, Hubbell JA. Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix. Proc Natl Acad Sci U S A 2013;110:4563-4568.
24. Burdick JA, Murphy WL. Moving from static to dynamic complexity in hydrogel design. Nat Commun 2012;3:1269.
25. Nieto N, Lutolf MP. Extracellular matrix bioengineering and systems biology approaches in liver disease. Syst Synth Biol 2011;5:11-20.
26. Powers MJ, Domansky K, Kaazempur-Mofrad MR, Kalezi A, Capitano A, Upadhyaya A, et al. A microfabricated array bioreactor for perfused 3D liver culture. Biotechnol Bioeng 2002;78:257-269.
27. Lecluyse EL, Witek RP, Andersen ME, Powers MJ. Organotypic liver culture models: meeting current challenges in toxicity testing. Crit Rev Toxicol 2012;42:501-548.
28. van de Bovenkamp M. Precision-cut liver slices as a new model to study toxicity-induced hepatic stellate cell activation in a physiologic milieu. Toxicol Sci 2005;85:632-638.
29. Vickers AEM, Saulnier M, Cruz E, Merema MT, Rose K, Bentley P, et al. Organ slice viability extended for pathway characterization: an in vitro model to investigate fibrosis. Toxicol Sci 2004;82:534-544.
30. Guyot C, Lepreux S, Combe C, Sarrazy V, Billet F, Balabaud C, et al. Fibrogenic cell phenotype modifications during remodelling of normal and pathological human liver in cultured slices. Liver Int 2010;30:1529-1540.
31. Hadi M, Westra IM, Starokozhko V, Dragovic S, Merema MT, Groothuis GMM. Human precision-cut liver slices as an ex vivo model to study idiosyncratic drug-induced liver injury. Chem Res Toxicol 2013;26:710-720.
32. van Midwoud PM, Merema MT, Verweij N, Groothuis GMM, Verpoorte E. Hydrogel embedding of precision-cut liver slices in a microfluidic device improves drug metabolic activity. Biotechnol Bioeng 2011;108:1404-1412.
33. Prot JM, Leclerc E. The current status of alternatives to animal testing and predictive toxicology methods using liver microfluidic biochips. Ann Biomed Eng 2011;40:1228-1243.
34. Lee PJ, Hung PJ, Lee LP. An artificial liver sinusoid with a microfluidic endothelial-like barrier for primary hepatocyte culture. Biotechnol Bioeng 2007;97:1340-1346.
35. Goral VN, Yuen PK. Microfluidic platforms for hepatocyte cell culture: new technologies and applications. Ann Biomed Eng 2011;40:1244-1254.
36. Yamada M, Utoh R, Ohashi K, Tatsumi K, Yamato M, Okano T, et al. Controlled formation of heterotypic hepatic micro-organoids in anisotropic hydrogel microfibers for long-term preservation of liver-specific functions. Biomaterials 2012;33:8304-8315.
37. Wang Y, Toh Y-C, Li Q, Nugraha B, Zheng B, Lu TB, et al. Mechanical compaction directly modulates the dynamics of bile canaliculi formation. Integr Biol (Cambr) 2013;5:390.
38. Zeilinger K, Schreiter T, Darnell M, Söderdahl T, Lübberstedt M, Dillner B, et al. Scaling down of a clinical three-dimensional perfusion multicompartment hollow fiber liver bioreactor developed for extracorporeal liver support to an analytical scale device useful for hepatic pharmacological in vitro studies. Tissue Eng Part C Methods 2011;17:549-556.
39. Domansky K, Inman W, Serdy J, Dash A, Lim MH, Griffith LG. Perfused multiwell plate for 3D liver tissue engineering. Lab Chip 2010;10:51-58.
40. Ebrahimkhani MR, Nieman Shepard JA, Raredon MSB, Hughes DJ, Griffith LG. Bioreactor technologies to support liver function in vitro. Adv Drug Deliv Rev 2014 Mar 5. doi: 10.1016/j.addr.2014.02.011.
41. Yates C, Shepard CR, Papworth G, Dash A, Beer Stolz D, Tannenbaum S, et al. Novel three-dimensional organotypic liver bioreactor to directly visualize early events in metastatic progression. Adv Cancer Res 2007;97:225-246.
42. Schwartz RE, Trehan K, Andrus L, Sheahan TP, Ploss A, Duncan SA, et al. Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proc Natl Acad Sci U S A 2012;109:2544-2548.
43. Meredith LW, Harris HJ, Wilson GK, Fletcher NF, Balfe P, McKeating JA. Early infection events highlight the limited transmissibility of hepatitis C virus in vitro. J Hepatol 2013;58:1074-1080.
44. Shulla A, Randall G. Hepatitis C virus-host interactions, replication, and viral assembly. Curr Opin Virol 2012;2:725-732.
45. Kinney MA, McDevitt TC. Emerging strategies for spatiotemporal control of stem cell fate and morphogenesis. Trends Biotech 2013;31:78-84.
46. McCracken KW, Howell JC, Spence JR, Wells JM. Generating human intestinal tissue from pluripotent stem cells in vitro. Nat Protoc 2011;6:1920-1928.
47. Matsumoto K, Zaret KS. Liver organogenesis promoted by endothelial cells prior to vascular function. Science 2001;294:559-563.
48. Gouon-Evans V, Boussemart L, Gadue P, Nierhoff D, Koehler CI, Kubo A, et al. BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm. Nat Biotechnol 2006;24:1402-1411.
49. Takebe T, Sekine K, Enomura M, Koike H, Kimura M, Ogaeri T, et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 2014;499:481-484.
50. Peerani R, Zandstra PW. Enabling stem cell therapies through synthetic stem cell-niche engineering. J Clin Invest 2010;120:60-70.
51. Woodford C, Zandstra PW. Tissue engineering 2.0: guiding self-organization during pluripotent stem cell differentiation. Curr Opin Biotechnol 2012;23:810-819.
52. Salazar-Ciudad I, Jernvall J. A computational model of teeth and the developmental origins of morphological variation. Nature 2010;464:583-586.
53. Osterfield M, Du X, Schüpbach T, Wieschaus E, Shvartsman SY. Three-dimensional epithelial morphogenesis in the developing drosophila egg. Dev Cell 2013;24:400-410.
54. Tujios S, Fontana RJ. Mechanisms of drug-induced liver injury: from bedside to bench. Nat Rev Gastroenterol Hepatol 2011;8:202-211.
55. Opar A. Overtaking the DILI model-T. Nat Rev Drug Discov 2012;11:585-586.
56. Cosgrove BD, Alexopoulos LG, Hang TC, Hendriks BS, Sorger PK, Griffith LG, et al. Cytokine-associated drug toxicity in human hepatocytes is associated with signaling network dysregulation. Mol Biosyst 2010;6:1195-1206.
57. Dash A, Inman W, Hoffmaster K, Sevidal S, Kelly J, Obach RS, et al. Liver tissue engineering in the evaluation of drug safety. Expert Opin Drug Metab Toxicol 2009;5:1159-1174.
58. Daly AK. Pharmacogenomics of adverse drug reactions. Genome Med 2013;5:5.
59. Tatonetti NP, Ye PP, Daneshjou R, Altman RB. Data-driven prediction of drug effects and interactions. Sci Transl Med 2012;4:125ra31.
60. Lau KS, Cortez-Retamozo V, Philips SR, Pittet MJ, Lauffenburger DA, Haigis KM. Multi-scale in vivo systems analysis reveals the influence of immune cells on tnf-α-induced apoptosis in the intestinal epithelium. PLoS Biol 2012;10:e1001393.
61. Di L, Atkinson K, Orozco CC, Funk C, Zhang H, McDonald TS, et al. In vitro-in vivo correlation for low-clearance compounds using hepatocyte relay method. Drug Metab Dispos 2013;41:2018-2023.
62. Diehl AM, Chute J. Underlying potential: cellular and molecular determinants of adult liver repair. J Clin Invest 2013;123:1858-1860.